Mineralys files Form 144 to sell 2,170 shares

Mineralys Therapeutics filed a Form 144 notice reporting a proposed sale of 2,170 shares of Common Stock via a broker-assisted cashless exercise on 06/10/2026.

Rhea-AI Filing Summary

Mineralys Therapeutics filed a Form 144 notice reporting a proposed sale of 2,170 shares of Common Stock via a broker-assisted cashless exercise on 06/10/2026. The filing lists multiple recent dispositions by the reporting person between 03/09/2026 and 05/18/2026, including sales of 14,058 shares on 03/13/2026 for $369,225.07 and repeated smaller transactions. This notice documents affiliated share sales and an associated cashless exercise; timing and settlement mechanics are described as a broker-assisted cashless exercise.

Insights

Securities Compliance Analyst

Form 144 documents a proposed affiliate sale and a broker-assisted cashless exercise of employee options.

The filing lists a proposed sale of 2,170 shares on 06/10/2026 described as an "Exercise of employee stock options" executed via "broker assisted cashless exercise." Several prior dispositions over the prior three months are itemized with dates, share counts, and gross proceeds.

These entries are routine regulatory notices required for affiliate sales. Cash treatment and exact settlement dates follow broker procedures; subsequent filings may disclose completed transaction details.

Key Figures

Proposed shares to be sold: 2,170 shares Sale example: 14,058 shares Sale example: 6,348 shares +2 more

5 metrics

Proposed shares to be sold 2,170 shares Exercise of employee stock options on 06/10/2026

Sale example 14,058 shares Sold 03/13/2026 for $369,225.07

Sale example 6,348 shares Multiple sales including 03/12/2026 for $173,748.15 and 05/12/2026 for $186,348.35

Sale example 2,171 shares Sold 05/11/2026 for $64,500.41

Recent small sale 417 shares Sold 05/18/2026 for $11,488.35

Key Terms

broker-assisted cashless exercise, Form 144, employee stock options

3 terms

broker-assisted cashless exercise financial

"Broker assisted cashless exercise"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

employee stock options financial

"Exercise of employee stock options"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Mineralys Therapeutics' Form 144 on 06/10/2026 report?

It reports a proposed sale of 2,170 shares via a broker-assisted cashless exercise on 06/10/2026. The filing catalogs the method as an exercise of employee stock options and lists prior dispositions in the preceding three months.

Who is the reporting person named in the Form 144 for MLYS?

The filing identifies transactions attributed to David Rodman at the Radnor address. Multiple sales by this reporting person between 03/09/2026 and 05/18/2026 are itemized with share counts and gross proceeds.

How many shares were proposed for sale and by what method?

The notice lists a proposed sale of 2,170 shares described as an "Exercise of employee stock options" completed through a broker-assisted cashless exercise on 06/10/2026.

Does the Form 144 show recent past sales and proceeds for the reporting person?

Yes. The filing lists several past sales, for example 14,058 shares sold on 03/13/2026 for $369,225.07 and other dated transactions with their respective gross proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 04:11 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001672659
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Mineralys Therapeutics, Inc.
SEC File Number	001-41614
Address of Issuer	150 N. RADNOR CHESTER RD. SUITE F200 RADNOR PENNSYLVANIA 19087
Phone	(888) 378-6240
Name of Person for Whose Account the Securities are To Be Sold	Rodman David Malcom
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	2170	54250.00	82498101	06/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common stock	06/10/2026	Exercise of employee stock options	Mineralys Therapeutics, Inc.			2170	06/10/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/09/2026	2171	58269.64
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/12/2026	6348	173748.15
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/13/2026	14058	369225.07
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/17/2026	417	10696.05
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/09/2026	2170	59414.60
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/13/2026	14058	373086.81
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/15/2026	6348	175585.68
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/17/2026	416	13033.28
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	05/11/2026	2171	64500.41
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	05/12/2026	6348	186348.35
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	05/13/2026	14056	401789.92
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	05/18/2026	417	11488.35

144: Remarks and Signature

Remarks
Date of Notice	06/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David Rodman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)